Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$626K Sell
6,500
-400
-6% -$40K ﹤0.01% 919
2025
Q4
$671K Sell
6,900
-1,900
-22% -$163K ﹤0.01% 860
2025
Q3
$626K Sell
8,800
-500
-5% -$33.3K ﹤0.01% 901
2025
Q2
$556K Sell
9,300
-800
-8% -$43.8K ﹤0.01% 1195
2025
Q1
$530K Sell
10,100
-1,200
-11% -$67.4K ﹤0.01% 1140
2024
Q4
$622K Buy
11,300
+4,500
+66% +$237K ﹤0.01% 1043
2024
Q3
$342K Sell
6,800
-2,700
-28% -$125K ﹤0.01% 1408
2024
Q2
$417K Sell
9,500
-2,500
-21% -$106K ﹤0.01% 1333
2024
Q1
$527K Sell
12,000
-800
-6% -$35.4K ﹤0.01% 1225
2023
Q4
$607K Hold
12,800
﹤0.01% 1158
2023
Q3
$567K Buy
12,800
+1,000
+8% +$46.5K ﹤0.01% 1178
2023
Q2
$563K Sell
11,800
-1,800
-13% -$81.2K ﹤0.01% 1209
2023
Q1
$535K Sell
13,600
-2,100
-13% -$76.3K ﹤0.01% 1274
2022
Q4
$444K Hold
15,700
﹤0.01% 1372
2022
Q3
$471K Hold
15,700
﹤0.01% 1354
2022
Q2
$532K Buy
15,700
+900
+6% +$32.3K ﹤0.01% 1325
2022
Q1
$663K Sell
14,800
-2,000
-12% -$92.5K ﹤0.01% 1313
2021
Q4
$776K Buy
16,800
+4,900
+41% +$198K ﹤0.01% 1295
2021
Q3
$399K Hold
11,900
﹤0.01% 1582
2021
Q2
$349K Buy
11,900
+1,100
+10% +$30.3K ﹤0.01% 1669
2021
Q1
$278K Hold
10,800
﹤0.01% 1731
2020
Q4
$246K Sell
10,800
-1,000
-8% -$23.1K ﹤0.01% 1697
2020
Q3
$252K Sell
11,800
-9,200
-44% -$207K ﹤0.01% 1605
2020
Q2
$487K Buy
21,000
+900
+4% +$19.3K ﹤0.01% 1327
2020
Q1
$429K Hold
20,100
﹤0.01% 1244
2019
Q4
$469K Hold
20,100
﹤0.01% 1469
2019
Q3
$422K Hold
20,100
﹤0.01% 1378
2019
Q2
$411K Buy
20,100
+1,400
+7% +$33K ﹤0.01% 1412
2019
Q1
$525K Hold
18,700
﹤0.01% 1245
2018
Q4
$457K Buy
18,700
+2,367
+14% +$63.6K ﹤0.01% 1301
2018
Q3
$606K Buy
16,333
+11,833
+263% +$319K ﹤0.01% 1280
2018
Q2
$93K Buy
+4,500
New +$79.5K ﹤0.01% 1881
2016
Q3
Sell
-3,600
Closed -$66.7K 1929
2016
Q2
$78K Hold
3,600
﹤0.01% 1713
2016
Q1
$68K Hold
3,600
﹤0.01% 1738
2015
Q4
$100K Buy
3,600
+2,700
+300% +$76.3K ﹤0.01% 1683
2015
Q3
$21K Hold
900
﹤0.01% 1815
2015
Q2
$20K Buy
+900
New +$16.4K ﹤0.01% 1817

Other funds holding IRMD

STRS Ohio's IRMD Position: Q1 2026 in Review

STRS Ohio reduced its iRadimed (IRMD) stake by 5.8% in Q1 2026, selling an estimated $40K and leaving 6,500 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #919.

STRS Ohio first reported a position in IRMD in Q2 2015 and has held it in 37 quarters since. The position peaked at $776K in Q4 2021. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • STRS Ohio held 6,500 shares of iRadimed worth $626K as of Q1 2026.
  • STRS Ohio sold 400 iRadimed shares in Q1 2026, an estimated $40K.
  • iRadimed made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #919 holding.
  • STRS Ohio first reported a position in iRadimed in Q2 2015 and has held it in 37 quarters since.
  • STRS Ohio's iRadimed position peaked at $776K in Q4 2021.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.